What are the causes and management of leukocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Leukocytosis

Leukocytosis is most commonly caused by infections or inflammatory processes, but can also result from physiologic stress, medications, or primary bone marrow disorders requiring different management approaches depending on the underlying etiology and severity.

Definition and Classification

  • Leukocytosis: White blood cell (WBC) count >11,000/μL in non-pregnant adults 1
  • Severity classification 2:
    • Mild: 1,000-1,500/μL
    • Moderate: 500-1,000/μL
    • Severe: <500/μL (requires urgent attention)
    • Critical: >100,000/μL (medical emergency due to risk of brain infarction and hemorrhage) 1

Common Causes of Leukocytosis

1. Infections

  • Bacterial infections (most common cause)
  • Viral infections
  • Fungal infections
  • Parasitic infections

2. Inflammatory Conditions

  • Autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus)
  • Tissue damage/necrosis
  • Vasculitis
  • Adult-onset Still's disease (characterized by striking neutrophilia with peripheral WBC counts often >15,000 cells/μL, with some patients having counts >20,000) 3

3. Physiologic Stress

  • Physical stress (seizures, anesthesia, overexertion)
  • Emotional stress
  • Pregnancy
  • Post-surgical states

4. Medication-Induced

  • Corticosteroids
  • Lithium
  • Beta-agonists
  • Epinephrine
  • G-CSF (filgrastim)
  • Certain antibiotics

5. Primary Bone Marrow Disorders

  • Acute leukemias
    • Acute myeloid leukemia (AML)
    • Acute lymphoblastic leukemia (ALL)
  • Chronic leukemias
    • Chronic myeloid leukemia (CML)
    • Chronic lymphocytic leukemia (CLL)
  • Myeloproliferative disorders
    • Polycythemia vera
    • Essential thrombocythemia
    • Primary myelofibrosis

6. Other Causes

  • Splenectomy or hyposplenism
  • Hemolysis
  • Smoking
  • Tissue injury
  • Malignancy (solid tumors)
  • Kawasaki disease (in children) 3

Red Flags for Primary Bone Marrow Disorders

  • Extremely elevated WBC counts (especially >50,000/μL)
  • Concurrent abnormalities in red blood cell or platelet counts
  • Weight loss, night sweats, or fever
  • Bleeding or bruising
  • Hepatosplenomegaly or lymphadenopathy
  • Immunosuppression 1, 4

Evaluation of Leukocytosis

Initial Assessment

  1. Determine which WBC subpopulation is increased:

    • Neutrophilia (most common)
    • Lymphocytosis
    • Monocytosis
    • Eosinophilia
    • Basophilia
  2. Review peripheral blood smear for:

    • Presence of immature cells ("left shift")
    • Abnormal cell morphology
    • Blasts (suggestive of acute leukemia)
  3. Assess for associated symptoms:

    • Fever, chills (infection)
    • Joint pain, rash (inflammatory conditions)
    • Constitutional symptoms (weight loss, night sweats, fatigue)

Additional Testing Based on Clinical Suspicion

  • Complete blood count with differential
  • Blood cultures (if infection suspected)
  • Inflammatory markers (ESR, CRP)
  • Bone marrow aspiration/biopsy (if primary bone marrow disorder suspected)
  • Imaging studies as indicated
  • Specialized molecular testing for leukemia diagnosis

Management Approach

Emergency Management

  • WBC counts >100,000/μL require immediate intervention due to risk of leukostasis 1
  • In CML with symptomatic leukocytosis: hydroxyurea, apheresis, imatinib, or clinical trial 3
  • In acute leukemia: prompt referral to hematology and consideration of induction chemotherapy 3

Infection-Related Leukocytosis

  • Identify and treat the underlying infection
  • Appropriate antimicrobial therapy based on suspected source

Medication-Induced Leukocytosis

  • Consider dose reduction or discontinuation of offending medication if clinically appropriate 2

Inflammatory Condition-Related Leukocytosis

  • Treat the underlying inflammatory condition
  • Anti-inflammatory medications as appropriate

Primary Bone Marrow Disorders

  • Acute leukemia: Induction chemotherapy with cytarabine and anthracycline 3, 2
  • CML: Tyrosine kinase inhibitors (e.g., imatinib) 2
  • CLL: Treatment decisions based on disease stage and genetic factors 3, 2

Special Considerations

  • "Unexplained" leukocytosis in hospitalized patients may represent persistent inflammation-immunosuppression and catabolism syndrome (PICS) rather than ongoing infection 5
  • Excessive antibiotic use in patients with non-infectious leukocytosis should be avoided
  • Leukocytosis with eosinophilia (>500 cells/μL) may indicate allergic reactions, parasitic infections, or certain malignancies 5

Remember that while leukocytosis is often a response to infection or inflammation, persistent or severe leukocytosis without obvious cause warrants thorough investigation to rule out primary bone marrow disorders.

References

Research

Leukocytosis: basics of clinical assessment.

American family physician, 2000

Guideline

Management of Leucopenia in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Inpatients With 'Unexplained' Leukocytosis.

The American journal of medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.